Search results for "tips"

showing 10 items of 280 documents

Adjunctive clotiapine for the management of delusions in two adolescents with anorexia nervosa

2021

Clotiapine is an atypical antipsychotic indicated for the management of a series of acute psychotic disorders. The current literature lacks evidence concerning the tolerability and clinical use of this drug in the management of individuals with anorexia nervosa (AN). In this study, we report two cases of adolescents with AN, treated with clotiapine. The reason for the administration of clotiapine was, for both patients, the manifestation of bizarre delusions concerning food and calories. Patient 1 presented a presyncope after the first dose of clotiapine, and treatment was rapidly discontinued. Patient 2 was treated with clotiapine for 9 months; doses were titrated from 20 mg/day to 70 mg/d…

Inpatient treatmentAnorexia nervosaDevelopmentAdolescentsArticleBF1-990Behavioral Neuroscienceclotiapine; anorexia nervosa; eating disorders; adolescents; inpatient treatment; antipsychoticseating disorderadolescentGeneticsEating disordersPsychologyAntipsychoticsGeneral PsychologyEcology Evolution Behavior and SystematicsClotiapine
researchProduct

Phenothiazines interfere with dopaminergic neurodegeneration in Caenorhabditis elegans models of Parkinson's disease

2010

Oxidative stress is involved in the pathogenesis of various neurodegenerative disorders, conventional antioxidant strategies have yet been of limited success. We have employed transgenic Caenorhabditis elegans expressing DsRed2 in dopaminergic neurons and CFP pan-neuronally, to characterize in larval and adult animals the effects of rotenone and 1-methyl-4-phenyl-pyridinium (MPP(+)) on the dopaminergic system. Investigating the antioxidant phenothiazine and different derived antipsychotic drugs, it was found that free phenothiazine exerted strong neuroprotection at the cellular level and resulted in a better performance in behavioral assays, whereas apomorphine and other dopamine agonists o…

InsecticidesApomorphineChlorpromazineDopamineBiologyPharmacologyNeuroprotectionlcsh:RC321-571Animals Genetically Modifiedchemistry.chemical_compoundAntipsychotic drugParkinsonian DisordersDopaminePhenothiazinesRotenonemedicineAnimalsHumansChlorpromazineCaenorhabditis eleganslcsh:Neurosciences. Biological psychiatry. Neuropsychiatrychemistry.chemical_classificationNeuronsDopaminergic neuronModels GeneticNeurodegenerationDopaminergicRotenonemedicine.diseaseDisease Models AnimalNeuroprotective AgentsNeurologychemistryDopamine receptorNerve DegenerationAntioxidantTricyclicmedicine.drugAntipsychotic AgentsNeurobiology of Disease
researchProduct

Izglītības vadība (Latvijas Universitātes raksti; 749. sēj.)

2009

Late-careerSvešvalodu skolotāju programmasVeselības uzvedības teorētiskie modeļiStarptautiskā diplomatzīšanaLisbon Recognition ConventionStrukturālo vienādojumu modelēšanaAugstākās izglītības pieejamībaMācību sasniegumiAtklātā pirmkoda programmatūraTiešsaistes mācīšanāsSociotipsTeatcher educationSkolotāju darbības vērtējumsStudiju programmas īstenošanas kvalitāteAtkārtošanāsSelf-conceptPedagoga autoritātePedagoģiskā diskursa efektivitāteScholl leadershipIzglītības iestādes vadītājsAugstskolas informatīvā sistēmaIzglītības vadība
researchProduct

Logotipu semiotiskā analīze un auditorijas uztveres pētījums. 2018. gada Latvijas mīlētāko zīmolu topa piemērs

2019

Bakalaura tēma ir “Logotipu semiotiskā analīze un auditorijas uztveres pētījums. 2018. gada Latvijas mīlētāko zīmolu topa piemērs”. Darbā gaitā tika atlasīti 50 zīmolu logotipi, kuriem tika veikta semiotiskā analīze, kā arī tie tika izmantoti auditorijas uztveres pētījumā. Darba teorētiskajā daļā tika aplūkota logotipu vēsture, izcelsme kā arī to veidi. Tika aplūkota arī semiotika un iespējamie zīmju uztveršanas veidi, kā arī zīmju iedalījums pēc to nozīmes. Darba metodoloģiskajā un arī empīriskajā daļā, ir aplūkotas un pielietotas tādas pētniecības metodes kā semiotiskā analīze, interneta aptauja, fokusgrupas diskusija un intervija. Darba mērķis ir noskaidrot kā cilvēki uztver zīmolu logot…

Latvijas mīlētāko zīmolu topslogotipsauditorijasemiotiskā analīzeKomunikācijas zinātneuztvere
researchProduct

From the periphery of discourse : Maria-Merce Marçal and Dolors Miquel

2017

L’article analitza diverses estratègies utilitzades per dues poetes catalanes, Maria-Mercè Marçal i Dolors Miquel, per desconstruir els discursos mitjançant els quals s’han construït els rols de gènere. Assenyalarem algunes coincidències entre les dues poetes com el fet que ambdues reformulin els estereotips femenins, que presentin un jo líric fragmentat i canviant, i que dialoguin amb les sagrades escriptures, reescrivint el parenostre i feminitzant Déu. Tant Maria-Mercè Marçal com Dolors Miquel aborden a través del discurs poètic alguns dels anhels, propostes i debats dels moviments feministes contemporanis.

Linguistics and LanguageUNESCO::CIENCIAS DE LAS ARTES Y LAS LETRAS:CIENCIAS DE LAS ARTES Y LAS LETRAS [UNESCO]FeminismeMaria-Mercè Marçal; Dolors Miquel; estereotips femenins; subjecte androcèntric; feminització de DéuDéu -- FeminitatDolors Miquel 1960 -Marçal Maria-Mercè 1952-1998 -- Crítica i interpretacióLanguage and Linguistics
researchProduct

Transjugular intrahepatic portosystemic shunt (TIPS) complications: what diagnostic radiologists should know

2022

Transjugular intrahepatic portosystemic shunt (TIPS) is an effective therapy for portal hypertension complications and can successfully treat variceal bleeding and refractory ascites. Although TIPS is relatively safe, procedural- or shunt-related morbidity can reach 20%, and procedural complications have a fatality rate of 2%. Delayed recognition and treatment of TIPS complications can lead to life-threatening clinical scenarios. Complications can vary from stent migration or malpositioning to nontarget organ injury, TIPS dysfunction, encephalopathy, or liver failure. This review aims to outline the role of diagnostic radiology in assessing post-TIPS complications.[GRAPHICS].

Liver CirrhosisComplicationsRadiological and Ultrasound TechnologyUrologyGastroenterologyEsophageal and Gastric VaricesTransjugular intrahepatic portosystemic shuntImagingTreatment OutcomeHepatic EncephalopathyRadiologistsTIPSHumansRadiology Nuclear Medicine and imagingPortasystemic Shunt Transjugular IntrahepaticGastrointestinal HemorrhageAbdominal Radiology
researchProduct

Real-world effectiveness of long acting aripiprazole: Treatment persistence and its correlates in the Italian clinical practice

2019

Abstract Objectives To identify the variables that are associated with persistence to Aripiprazole-Long Acting (A-LAI), in adult patients with schizophrenia. Methods Observational, retrospective, non-interventional study involving 261 patients with schizophrenia. Results Eighty-six percent of study subjects were persistent for at least 6 months. All subjects with baseline CGI-S of 1 or 2, 95% of subjects with CGI-S of 3, 86% with CGI-S of 4, 82% of subjects with CGI-S of 5, 73% of subjects with CGI of 6 and 90% of subjects with CGI of 7 were persistent. A-LAI treatment continuation rate was higher in patients with: 1) baseline CGI score ≤ 4; 2) schizophrenia dimension (LDPS) mania score ≤ 5…

Long actingMaleAdherence; Aripiprazole; Long acting; Maintena; Persistence; Personalized; Psychiatry and Mental Health; Biological PsychiatryAdherence; Aripiprazole; Long acting; Maintena; Persistence; Personalized; Adult; Antipsychotic Agents; Aripiprazole; Delayed-Action Preparations; Female; Humans; Italy; Male; Medication Adherence; Middle Aged; Retrospective Studies; Schizophrenia; Treatment OutcomePersonalizedAripiprazole0302 clinical medicineRetrospective StudieDelayed-Action PreparationMaintenaMiddle AgedhumanitiesClinical PracticeTreatment OutcomeItalySchizophreniaPsychiatry and Mental HealthAripiprazoleFemaleBiological psychiatrymedicine.symptomManiaHumanmedicine.drugAntipsychotic AgentsAdultmedicine.medical_specialtyMedication AdherencePersistence03 medical and health scienceshealth services administrationInternal medicinemental disordersmedicineTreatment persistenceHumansBiological PsychiatryRetrospective Studiesbusiness.industryRetrospective cohort studymedicine.diseaseAdherence; Aripiprazole; Long acting; Maintena; Persistence; Personalized;030227 psychiatryAntipsychotic AgentLong actingAdherenceDelayed-Action PreparationsSchizophreniabusiness030217 neurology & neurosurgery
researchProduct

Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Ne…

2022

Introduction: Information on the off–label use of Long–Acting Injectable (LAI) antipsychotics in the real world is lacking. In this study, we aimed to identify the sociodemographic and clinical features of patients treated with on– vs off–label LAIs and predictors of off–label First– or Second–Generation Antipsychotic (FGA vs. SGA) LAI choice in everyday clinical practice. Method: In a naturalistic national cohort of 449 patients who initiated LAI treatment in the STAR Network Depot Study, two groups were identified based on off– or on–label prescriptions. A multivariate logistic regression analysis was used to test several clinically relevant variables and identify those associated with th…

Long-acting injectable antipsychoticCross-Sectional StudiesOff-labelPersonality disorderBipolar disorderDelayed-Action PreparationsSchizophreniaHumansBipolar disorder; Long-acting injectable antipsychotics; Off-label; Personality disorder; Schizophrenia; Cross-Sectional Studies; Delayed-Action Preparations; Humans; Off-Label Use; Antipsychotic Agents; SchizophreniaOff-Label UseSettore MED/25 - PsichiatriaLong-acting injectable antipsychoticsAntipsychotic Agents
researchProduct

Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disor…

2022

In this prospective study, we assessed the effectiveness and acceptability of paliperidone palmitate 1-month (PP1M) and aripiprazole monohydrate (AM) over 1-year follow-up. We included 195 subjects (117 treated with PP1M and 78 with AM) with schizophrenia spectrum disorders from real-world settings. We estimated no differences in hospitalization (Odds Ratio=1.59; p = 0.12), symptoms improvement (p = 0.90 adjusted for baseline severity), and discontinuation (Hazard Ratio=0.72; p = 0.20) at study endpoint. Although current evidence suggests the possible superiority of AM over PP1M, our findings showed comparable effectiveness between these drugs. Additional studies in real-world settings with…

Long-acting injectable antipsychoticPaliperidone palmitate 1-monthAripiprazoleAripiprazole monohydrateLong-acting injectable antipsychoticsPsychiatry and Mental healthPaliperidone PalmitateSchizophreniaHumansProspective StudiesSettore MED/25 - PsichiatriaBiological PsychiatryAripiprazole monohydrate; Long-acting injectable antipsychotics; Paliperidone palmitate 1-monthAntipsychotic Agents
researchProduct

Synthesis and characterization of biotinylated and photoactivatable neuroleptics. Novel bifunctional probes for dopamine receptors

1992

Abstract We have synthesized and characterized a series of novel derivatives of established antagonists of the neurotransmitter dopamine, i.e. butyrophenones, hexahydrocarbolines and phenothiazenes. All derivatives were biotinylated, some of them carried an additional (photoactivatable) azido group. In the case of butyrophenones, the structural modifications were introduced at the aliphatic keto group and/or the heterocyclic ring system, both modifications resulting in significant decreases in binding affinity to dopamine D 2 and dopamine D 1 receptor subtypes. Biotinylation of hexahydrocarbolines significantly increased their binding affinity to D 1 receptors, with the affinity for D 2 rec…

Magnetic Resonance SpectroscopySpectrophotometry InfraredPhotochemistryButyrophenoneStereochemistryBiotinIn Vitro TechniquesLigandsBinding CompetitiveReceptors DopamineStructure-Activity Relationship03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDopaminemedicineAnimalsNeurotransmitterReceptor030304 developmental biologyPharmacology0303 health sciencesDopamine antagonistAffinity LabelsBenzazepineschemistryBiochemistrySpiperoneDopamine receptorBiotinylationCattleButyrophenones030217 neurology & neurosurgeryAntipsychotic Agentsmedicine.drugEuropean Journal of Pharmacology: Molecular Pharmacology
researchProduct